Trailing-twelve-month (TTM) net income is $3.17 Billion with a year-over-year change of (80.66%). Net income represents the company's bottom line profit after all expenses, taxes, and interest.
Reported quarterly net income; no daily interpolation. Q2 FY2026 (2026-06-30): $-1.33B.
Net Income growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-09-10T17:20:40.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
$3.17B
$3.17 Billion
(80.66%)
vs. $16.41B a year ago (TTM)
+20.90%
5 Year compound annual growth rate
1 Year
(80.66%)
3 Year
(12.69%)
5 Year
+20.90%
10 Year
(4.70%)
15 Year
(1.93%)
20 Year
(2.77%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Net Income | YoY Change | % Change |
|---|---|---|---|
| 2025 | $18.25B | +$1.14B | +6.64% |
| 2024 | $17.12B | +$16.75B | +4589.59% |
| 2023 | $365.00M | ($14.15B) | (97.49%) |
| 2022 | $14.52B | +$1.47B | +11.27% |
| 2021 | $13.05B | +$5.98B | +84.65% |
| 2020 |
TTM Growth
(80.66%)
3-Year CAGR
(12.69%)
5-Year CAGR
(10.65%)
Unrounded diluted TTM EPS / FMP quote price × 100 Quote observation: 2026-09-10T17:20:40.000Z. Historical observations retain their original dates. Historical series through 2026-09-09.
| $7.07B |
| ($2.78B) |
| (28.20%) |
| 2019 | $9.84B | +$3.62B | +58.25% |
| 2018 | $6.22B | +$3.83B | +159.82% |
| 2017 | $2.39B | ($1.53B) | (38.93%) |
| 2016 | $3.92B | ($522.00M) | (11.75%) |
